MarketCap
Agios Pharmaceuticals AGIO
$ 33.6
0.16%
Facebook
X
Telegram
Agios Pharmaceuticals Historical Prices | AGIO
Annual Historical Prices Agios Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.1 | 33.3 | 26.8 | 25.9 | 32.9 | 43.3 | 47.8 | 46.1 | 57.2 | 41.7 | 64.9 | 112 | 23.9 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 112 | 23.9 | 44.9 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AbbVie
ABBV
|
226 | $ 257.12 | 0.86 % | $ 455 B |  USA |
 |
AbCellera Biologics
ABCL
|
3.22 | $ 10.89 | 4.11 % | $ 3.25 B |  Canada |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M |  Israel |
 |
Amryt Pharma plc
AMYT
|
10.8 | - | - | $ 621 M |  Britain |
 |
Evelo Biosciences
EVLO
|
0.31 | - | -14.46 % | $ 27.9 M | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
0.955 | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M | Britain |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
Abeona Therapeutics
ABEO
|
4.76 | $ 5.42 | 0.18 % | $ 287 M | USA |
 |
iTeos Therapeutics
ITOS
|
7.24 | - | - | $ 411 M | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
0.74 | $ 4.63 | 21.05 % | $ 20 M | Israel |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
BioXcel Therapeutics
BTAI
|
1.26 | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
3.08 | $ 23.52 | 458.67 % | $ 98.9 M | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
1.63 | $ 2.0 | 0.3 % | $ 726 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
4.42 | $ 5.12 | 0.1 % | $ 981 M | Canada |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
NextCure
NXTC
|
12.7 | $ 7.0 | 0.55 % | $ 19.9 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
0.22 | - | 17.91 % | $ 11.1 M | USA |
 |
Nanobiotix S.A.
NBTX
|
30.3 | $ 37.01 | 0.27 % | $ 1.77 T |  France |
 |
ACADIA Pharmaceuticals
ACAD
|
21.7 | $ 27.83 | 0.32 % | $ 4.69 B | USA |
 |
Axcella Health
AXLA
|
0.46 | - | -16.42 % | $ 249 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
0.59 | - | 57.95 % | $ 12.8 M | USA |
 |
Atreca
BCEL
|
1.27 | - | -11.76 % | $ 5.79 M | USA |
 |
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
8.23 | - | -74.18 % | $ 955 K | USA |
 |
Achieve Life Sciences
ACHV
|
2.9 | $ 7.06 | 0.41 % | $ 308 M | USA |
 |
Baudax Bio
BXRX
|
2.35 | - | 0.59 % | $ 63 K | USA |
 |
Calithera Biosciences
CALA
|
13.3 | - | -10.95 % | $ 876 K | USA |
 |
CymaBay Therapeutics
CBAY
|
32.3 | - | - | $ 3.45 B | USA |
 |
Codiak BioSciences
CDAK
|
11.1 | - | -55.98 % | $ 2.15 M | USA |
 |
ChemoCentryx
CCXI
|
26.9 | - | - | $ 3.74 B | USA |
 |
Avid Bioservices
CDMO
|
6.7 | - | - | $ 789 M | USA |
 |
AC Immune SA
ACIU
|
2.85 | $ 2.76 | 2.6 % | $ 278 M |  Schweiz |
|
Cerevel Therapeutics Holdings
CERE
|
41.2 | - | - | $ 7.29 B | USA |
 |
Aclaris Therapeutics
ACRS
|
3.14 | $ 5.32 | 1.27 % | $ 652 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
4.04 | - | - | $ 169 M | USA |
 |
Adagene
ADAG
|
3.8 | $ 3.4 | 2.72 % | $ 201 M |  China |
 |
ADC Therapeutics SA
ADCT
|
1.09 | $ 1.07 | 0.45 % | $ 136 M | Schweiz |
 |
Adial Pharmaceuticals
ADIL
|
1.96 | $ 4.9 | 0.08 % | $ 3.28 M | USA |
 |
ADMA Biologics
ADMA
|
15.9 | $ 9.23 | 0.16 % | $ 2.2 B | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
16.4 | $ 24.2 | 0.08 % | $ 3.67 B | USA |
 |
Agenus
AGEN
|
3.29 | $ 6.94 | 0.73 % | $ 206 M | USA |